Rachit Vakil, MD, MPH

Vakil is a postdoctoral fellow in the department of medicine at Johns Hopkins University School of Medicine

Most recent by Rachit Vakil, MD, MPH

SPONSORED CONTENT
December 16, 2019
5 min read
Save

Icosapent ethyl may act on plaque

A potential target for improving residual lipid-related risk for atherosclerotic CVD is reduction in triglyceride levels. Studies have shown eicosapentaenoic acid is effective in lowering triglyceride levels and reducing the risk for ischemic events in patients with elevated triglyceride levels already taking statin therapy.